These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18198633)

  • 41. [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles].
    Alban S
    Hamostaseologie; 2008 Feb; 28(1-2):51-61. PubMed ID: 18278163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can we use a low molecular weight heparin after mechanical prosthetic heart valve surgery?
    Meurin P; Tabet JY
    Heart; 2008 Feb; 94(2):131-2. PubMed ID: 18195116
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thromboprophylaxis in the critically ill : Low molecular weight heparin versus unfractionated heparin].
    Petros S
    Med Klin Intensivmed Notfmed; 2016 Feb; 111(1):55-6. PubMed ID: 26374337
    [No Abstract]   [Full Text] [Related]  

  • 44. Biosimilars: considerations with low molecular weight heparins.
    Jackson CM
    Clin Adv Hematol Oncol; 2010 Mar; 8(3):163-7. PubMed ID: 20400930
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of low-molecular weight heparins to unfractionated heparin.
    Auer J; Berent R; Eber B
    Eur Heart J; 2001 Aug; 22(15):1359. PubMed ID: 11465971
    [No Abstract]   [Full Text] [Related]  

  • 46. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
    Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR
    Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of low-molecular-weight heparins in patients with prosthetic heart valves].
    Hering D; Horstkotte D
    Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.
    Bauersachs R; Lindhoff-Last E
    Arch Intern Med; 2003 Dec 8-22; 163(22):2788-9. PubMed ID: 14662636
    [No Abstract]   [Full Text] [Related]  

  • 49. [Anticoagulants and osteoporosis].
    Ferrière K; Rizzoli R
    Rev Med Suisse; 2007 Jun; 3(115):1508-11. PubMed ID: 17682793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G; Bernardi E
    Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 52. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Do we know all effects of heparins in hemodialyzed patients?].
    Sain M; Ljutić D; Kovacić V; Radić J; Jelicić I
    Acta Med Croatica; 2012 Jul; 66(3):215-20. PubMed ID: 23441536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin.
    Lambert JR; Austin SK; Peebles D; Cohen H
    Br J Haematol; 2008 Jul; 142(3):453-6. PubMed ID: 18510687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin in hypertriglyceridemia: friend or foe?
    Ng D
    J Lab Clin Med; 2001 Dec; 138(6):356-8. PubMed ID: 11753281
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of venous thromboembolism after ischemic stroke.
    Kase CS; Pineo GF
    Curr Opin Pulm Med; 2008 Sep; 14(5):389-96. PubMed ID: 18664967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin].
    Chigot P; De Gennes C; Samama MM
    J Mal Vasc; 1996; 21(3):121-5. PubMed ID: 8965038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of switching unfractionated heparin to low-molecular-weight heparin on serum potassium in hemodialysis patients.
    Ezzatzadegan Jahromi S; Mahmoodi MS; Behroozi F; Roozbeh J; Emamghoreishi F
    Iran J Kidney Dis; 2014 Nov; 8(6):475-80. PubMed ID: 25362223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Low molecular weight heparins].
    Schröder F; Weiss T
    Dtsch Med Wochenschr; 2002 Aug; 127(31-32):1645-7. PubMed ID: 12168158
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of venous thromboembolism in hospitalized medical patients.
    Lenchus JD; Jaffer AK
    Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.